Cargando…

Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents

Detalles Bibliográficos
Autores principales: Wang, Liang-Chuan S, Koblish, Holly, Hansbury, Michael, Zhang, Yue, Yang, Gengjie, Burn, Timothy, Waeltz, Paul, Rupar, Mark, Yue, Eddy, Douty, Brent, Maduskuie, Thomas, Falahatpisheh, Nikoo, Li, Yun-Long, Combs, Andrew P, Hollis, Gregory, Huber, Reid, Scherle, Peggy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649283/
http://dx.doi.org/10.1186/2051-1426-3-S2-P377
_version_ 1782401324132859904
author Wang, Liang-Chuan S
Koblish, Holly
Hansbury, Michael
Zhang, Yue
Yang, Gengjie
Burn, Timothy
Waeltz, Paul
Rupar, Mark
Yue, Eddy
Douty, Brent
Maduskuie, Thomas
Falahatpisheh, Nikoo
Li, Yun-Long
Combs, Andrew P
Hollis, Gregory
Huber, Reid
Scherle, Peggy
author_facet Wang, Liang-Chuan S
Koblish, Holly
Hansbury, Michael
Zhang, Yue
Yang, Gengjie
Burn, Timothy
Waeltz, Paul
Rupar, Mark
Yue, Eddy
Douty, Brent
Maduskuie, Thomas
Falahatpisheh, Nikoo
Li, Yun-Long
Combs, Andrew P
Hollis, Gregory
Huber, Reid
Scherle, Peggy
author_sort Wang, Liang-Chuan S
collection PubMed
description
format Online
Article
Text
id pubmed-4649283
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46492832015-11-24 Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents Wang, Liang-Chuan S Koblish, Holly Hansbury, Michael Zhang, Yue Yang, Gengjie Burn, Timothy Waeltz, Paul Rupar, Mark Yue, Eddy Douty, Brent Maduskuie, Thomas Falahatpisheh, Nikoo Li, Yun-Long Combs, Andrew P Hollis, Gregory Huber, Reid Scherle, Peggy J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649283/ http://dx.doi.org/10.1186/2051-1426-3-S2-P377 Text en Copyright © 2015 Wang et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Wang, Liang-Chuan S
Koblish, Holly
Hansbury, Michael
Zhang, Yue
Yang, Gengjie
Burn, Timothy
Waeltz, Paul
Rupar, Mark
Yue, Eddy
Douty, Brent
Maduskuie, Thomas
Falahatpisheh, Nikoo
Li, Yun-Long
Combs, Andrew P
Hollis, Gregory
Huber, Reid
Scherle, Peggy
Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents
title Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents
title_full Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents
title_fullStr Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents
title_full_unstemmed Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents
title_short Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents
title_sort pharmacological inactivation of pi3kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649283/
http://dx.doi.org/10.1186/2051-1426-3-S2-P377
work_keys_str_mv AT wangliangchuans pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents
AT koblishholly pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents
AT hansburymichael pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents
AT zhangyue pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents
AT yanggengjie pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents
AT burntimothy pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents
AT waeltzpaul pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents
AT ruparmark pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents
AT yueeddy pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents
AT doutybrent pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents
AT maduskuiethomas pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents
AT falahatpishehnikoo pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents
AT liyunlong pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents
AT combsandrewp pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents
AT hollisgregory pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents
AT huberreid pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents
AT scherlepeggy pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents